Statement of Changes in Beneficial Ownership (4)
July 07 2020 - 7:30PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Wenqing Yao |
2. Issuer Name and Ticker or Trading Symbol
INCYTE CORP
[
INCY
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, Head of Discovery Chem |
(Last)
(First)
(Middle)
1801 AUGUSTINE CUT-OFF |
3. Date of Earliest Transaction
(MM/DD/YYYY)
7/2/2020 |
(Street)
WILMINGTON, DE 19803
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 7/2/2020 | | A | | 6661 (1) | A | $0.00 | 158849 | D | |
Common Stock | 7/2/2020 | | F | | 2187 (2) | D | $106.47 | 156662 | D | |
Common Stock | 7/6/2020 | | F | | 404 (2) | D | $107.79 | 156258 | D | |
Common Stock | 7/6/2020 | | M | | 905 | A | $64.55 (3)(4)(5) | 157163 | D | |
Common Stock | 7/6/2020 | | S | | 905 | D | $107.32 | 156258 | D | |
Common Stock | 7/6/2020 | | M | | 15648 | A | $64.55 (3)(4)(5) | 171906 | D | |
Common Stock | 7/6/2020 | | S | | 15648 | D | $107.32 | 156258 (6) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Employee Stock Option (right to buy) | $106.47 | 7/2/2020 | | A | | 12743 | | (7) | 7/1/2030 | Common Stock | 12743 | $0.00 | 12743 | D | |
Incentive Stock Option (right to buy) | $64.55 | 7/6/2020 | | M | | | 905 | (8) | 1/20/2021 | Common Stock | 905 | $0.00 | 0 | D | |
Non-Qualified Stock Option (right to buy) | $64.55 | 7/6/2020 | | M | | | 15648 | (8) | 1/20/2021 | Common Stock | 15648 | $0.00 | 0 | D | |
Explanation of Responses: |
(1) | Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Wenqing Yao's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis. |
(2) | Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock. |
(3) | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. |
(4) | Represents weighted average sale price. Actual sale prices ranged from $105.66 - $108.48 |
(5) | Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. |
(6) | Including the July 2, 2020 Restricted Stock Unit Grant, this includes an aggregate of 96,857 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. |
(7) | Beginning July 2, 2020, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. |
(8) | Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Wenqing Yao 1801 AUGUSTINE CUT-OFF WILMINGTON, DE 19803 |
|
| EVP, Head of Discovery Chem |
|
Signatures
|
/s/ Wenqing Yao | | 7/7/2020 |
**Signature of Reporting Person | Date |
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Jul 2024 to Aug 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Aug 2023 to Aug 2024